[go: up one dir, main page]

WO2005049095A3 - Contrast agent imaging angiotensin ii receptors - Google Patents

Contrast agent imaging angiotensin ii receptors Download PDF

Info

Publication number
WO2005049095A3
WO2005049095A3 PCT/NO2004/000358 NO2004000358W WO2005049095A3 WO 2005049095 A3 WO2005049095 A3 WO 2005049095A3 NO 2004000358 W NO2004000358 W NO 2004000358W WO 2005049095 A3 WO2005049095 A3 WO 2005049095A3
Authority
WO
WIPO (PCT)
Prior art keywords
angiotensin
contrast agent
receptors
agent imaging
imaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/NO2004/000358
Other languages
French (fr)
Other versions
WO2005049095A2 (en
Inventor
Alan Cuthbertson
Magne Solbakken
Dagfinn Loevhaug
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Amersham Health AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NO20035228A external-priority patent/NO20035228D0/en
Priority claimed from GBGB0416062.8A external-priority patent/GB0416062D0/en
Application filed by Amersham Health AS filed Critical Amersham Health AS
Priority to EP04808852A priority Critical patent/EP1699494A2/en
Priority to US10/559,880 priority patent/US7431914B2/en
Priority to JP2006541065A priority patent/JP2007512321A/en
Publication of WO2005049095A2 publication Critical patent/WO2005049095A2/en
Publication of WO2005049095A3 publication Critical patent/WO2005049095A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

A contrast agent of formula I: V - L - R (I) where V is an organic group having binding affinity for an angiotensin II receptor site, L is a linear or branched amino acid-comprising biomodifier or linker moiety, and R is a reporter moiety detectable in in vivo imaging of a human or animal body.
PCT/NO2004/000358 2003-11-24 2004-11-23 Contrast agent imaging angiotensin ii receptors Ceased WO2005049095A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP04808852A EP1699494A2 (en) 2003-11-24 2004-11-23 Contrast agent imaging angiotensin ii receptors
US10/559,880 US7431914B2 (en) 2003-11-24 2004-11-23 Contrast agent
JP2006541065A JP2007512321A (en) 2003-11-24 2004-11-23 Contrast agent

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
NO20035228 2003-11-24
NO20035228A NO20035228D0 (en) 2003-11-24 2003-11-24 Imaging agents
GBGB0416062.8A GB0416062D0 (en) 2004-07-19 2004-07-19 Improved N4 chelator conjugates
GB0416062.8 2004-07-19

Publications (2)

Publication Number Publication Date
WO2005049095A2 WO2005049095A2 (en) 2005-06-02
WO2005049095A3 true WO2005049095A3 (en) 2006-01-12

Family

ID=34621675

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NO2004/000358 Ceased WO2005049095A2 (en) 2003-11-24 2004-11-23 Contrast agent imaging angiotensin ii receptors

Country Status (4)

Country Link
US (1) US7431914B2 (en)
EP (1) EP1699494A2 (en)
JP (1) JP2007512321A (en)
WO (1) WO2005049095A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0416062D0 (en) * 2004-07-19 2004-08-18 Amersham Plc Improved N4 chelator conjugates
KR20070091609A (en) * 2004-11-22 2007-09-11 지이 헬스케어 에이에스 Contrast Agents for Targeting Extracellular Matrix
US8926945B2 (en) 2005-10-07 2015-01-06 Guerbet Compounds comprising a biological target recognizing part, coupled to a signal part capable of complexing gallium
FR2891830B1 (en) 2005-10-07 2011-06-24 Guerbet Sa SHORT AMINOALCOHOL COMPOUNDS AND METAL COMPLEXES FOR MEDICAL IMAGING
US8986650B2 (en) 2005-10-07 2015-03-24 Guerbet Complex folate-NOTA-Ga68
GB0524987D0 (en) * 2005-12-08 2006-01-18 Ge Healthcare Ltd Novel imaging agents for fibrosis
US9364568B2 (en) 2010-07-15 2016-06-14 Warsaw Orthopedic, Inc. Methods to diagnose degenerative disc disease

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444069A (en) * 1990-10-02 1995-08-22 Warner-Lambert Company Imidazo-pyridine angiotensin II antagonists used to treat memory loss
WO1998018496A2 (en) * 1996-10-28 1998-05-07 Nycomed Imaging As Contrast agents
WO2003006491A2 (en) * 2001-07-10 2003-01-23 Amersham Health As Peptide-based compounds for targeting intergin receptors
WO2003006070A2 (en) * 2001-07-10 2003-01-23 Amersham Plc Improved chelator conjugates
WO2003051859A1 (en) * 2001-12-19 2003-06-26 Amersham Plc Compounds for imaging alzheimer's disease
WO2004062568A2 (en) * 2003-01-09 2004-07-29 Amersham Health As Conjugate of losartan, valsartan, candesartan or eprosartan and a chelant as contrast agent
WO2005030266A2 (en) * 2003-09-29 2005-04-07 Amersham Health As Optical imaging of colorectal cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138069A (en) 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
US5489425A (en) * 1987-06-24 1996-02-06 The Dow Chemical Company Functionalized polyamine chelants
US5264581A (en) 1992-05-29 1993-11-23 E. I. Du Pont De Nemours And Company Radioiodinated angiotensin receptor antagonists
US20040018203A1 (en) * 2001-06-08 2004-01-29 Ira Pastan Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates
US7211240B2 (en) * 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444069A (en) * 1990-10-02 1995-08-22 Warner-Lambert Company Imidazo-pyridine angiotensin II antagonists used to treat memory loss
WO1998018496A2 (en) * 1996-10-28 1998-05-07 Nycomed Imaging As Contrast agents
WO2003006491A2 (en) * 2001-07-10 2003-01-23 Amersham Health As Peptide-based compounds for targeting intergin receptors
WO2003006070A2 (en) * 2001-07-10 2003-01-23 Amersham Plc Improved chelator conjugates
WO2003051859A1 (en) * 2001-12-19 2003-06-26 Amersham Plc Compounds for imaging alzheimer's disease
WO2004062568A2 (en) * 2003-01-09 2004-07-29 Amersham Health As Conjugate of losartan, valsartan, candesartan or eprosartan and a chelant as contrast agent
WO2005030266A2 (en) * 2003-09-29 2005-04-07 Amersham Health As Optical imaging of colorectal cancer

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BURNS H D ET AL: "Development of [<11>C]L-159,884: A Radiolabelled, Nonpeptide Angiotensin II Antagonist that is Useful for Angiotensin II, AT1 Receptor Imaging", APPLIED RADIATION AND ISOTOPES, PERGAMON PRESS LTD., EXETER, GB, vol. 47, no. 2, February 1996 (1996-02-01), pages 211 - 218, XP004050601, ISSN: 0969-8043 *
PONCHANT M ET AL: "Radiosynthesis of [tetrazoyl-<11>C]irbesartan, a non-peptidic angiotensin II antagonist", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, EDITIONS SCIENTIFIQUE ELSEVIER, PARIS, FR, vol. 32, no. 9, September 1997 (1997-09-01), pages 747 - 752, XP004094071, ISSN: 0223-5234 *

Also Published As

Publication number Publication date
EP1699494A2 (en) 2006-09-13
JP2007512321A (en) 2007-05-17
US20060193768A1 (en) 2006-08-31
US7431914B2 (en) 2008-10-07
WO2005049095A2 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
WO1998018497A3 (en) Contrast agents
IL182898A0 (en) Contrast agents
WO2000056774A8 (en) Methods of using bioelastomers
WO1998018496A3 (en) Contrast agents
WO2006064451A3 (en) Targeting contrast agents or targeting therapeutic agents for molecular imaging and therapy
WO2001008712A3 (en) Targeting multimeric imaging agents through multilocus binding
WO2008050255A3 (en) Contrast agents for detecting prostate cancer
AU2003299934A8 (en) Implantable digestive tract organ
WO2003049684A3 (en) Pseudo-antibody constructs
EP2060272A3 (en) Vitamin-mitomycin conjugates
WO2007136468A3 (en) Devices and methods for endolumenal gastrointestinal bypass
WO2002094799A3 (en) Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
WO2001077145A3 (en) Integrin binding peptide derivatives
WO2005097219A3 (en) Ecm-based graft material
EP2269610A3 (en) Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
WO2008036147A3 (en) Drug delivery with stimulus responsive biopolymers
WO2005049095A3 (en) Contrast agent imaging angiotensin ii receptors
WO2001012233A3 (en) Sustained release formulation of a peptide
WO2005110982A3 (en) Substituted 1-benzyl-4-substituted piperazine analogues
EP2253333A3 (en) Contrast Agents for Myocardial Perfusion Imaging
WO2004025303A3 (en) Isoprostanes as markers of psychological stress in humans
ATE425770T1 (en) CONTRAST AGENTS
WO2002087497A3 (en) Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use
EP1833990A4 (en) MARKERS FOR DIAGNOSIS OF AML, B-ALL AND T-ALL
WO2005032399A3 (en) Il4 receptor antagonists for horse, dog and cat

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2006193768

Country of ref document: US

Ref document number: 10559880

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2004808852

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2006541065

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWE Wipo information: entry into national phase

Ref document number: 200480040615.1

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 10559880

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2004808852

Country of ref document: EP